Introduction The Fibrate Drugs Market is projected to grow steadily as the prevalence of dyslipidemia, hypertriglyceridemia, and cardiovascular disorders increases worldwide. Valued at USD 1.5 billion in 2024, the market is expected to reach USD 1.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 2.12%. Fibrate drugs are widely used to manage elevated triglyceride...